LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Technology MaxCyte's proprietary Flow Electroporation technology and the ExPERT™ platform support a rapidly expanding cell therapy market, creating opportunities to introduce advanced cellular processing solutions to biotech firms focused on next-generation therapies.

Strategic Partnerships Recent collaborations with companies like Moonlight Bio and ongoing licensing agreements highlight MaxCyte’s active role in forming strategic alliances, presenting potential sales channels for complementary products and enhanced platform integrations.

Financial Growth With reported revenues between 25 million and 50 million dollars and a focus on growth through innovation, MaxCyte offers a compelling opportunity for investors and partners seeking to align with a biotech leader in cell-engineering technologies.

Industry Recognition The appointment of MaxCyte’s CEO as Life Sciences CEO of the Year underscores strong industry credibility, paving the way for increased visibility among biotech and pharma clients seeking cutting-edge cell therapy solutions.

Expanding Leadership Recent leadership changes and upcoming key hires such as new CFO and additional directors indicate an organization poised for expansion, offering sales opportunities for management solutions, consulting, and strategic service providers.

MaxCyte, Inc. Tech Stack

MaxCyte, Inc. uses 8 technology products and services including GitHub, Akamai, Zendesk, and more. Explore MaxCyte, Inc.'s tech stack below.

  • GitHub
    Communication And Collaboration
  • Akamai
    Content Delivery Network
  • Zendesk
    Documentation Tools
  • Google Fonts API
    Font Scripts
  • OpenAI
    Generative Ai
  • DataTables
    Javascript Libraries
  • Acquia Cloud Platform
    Platform As A Service
  • C
    Programming Languages

Media & News

MaxCyte, Inc.'s Email Address Formats

MaxCyte, Inc. uses at least 1 format(s):
MaxCyte, Inc. Email FormatsExamplePercentage
FirstL@maxcyte.comJohnD@maxcyte.com
59%
FLast@maxcyte.comJDoe@maxcyte.com
32%
FirstLast@maxcyte.comJohnDoe@maxcyte.com
6%
Last@maxcyte.comDoe@maxcyte.com
3%

Frequently Asked Questions

Where is MaxCyte, Inc.'s headquarters located?

Minus sign iconPlus sign iconMaxCyte, Inc.'s main headquarters is located at 9713 Key West Avenue Suite 400 Rockville, Maryland 20850 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is MaxCyte, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact MaxCyte, Inc.'s main corporate office by phone at
+1-301-944-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MaxCyte, Inc.'s stock symbol?

Minus sign iconPlus sign iconMaxCyte, Inc. is a publicly traded company; the company's stock symbol is MXCT.

What is MaxCyte, Inc.'s official website and social media links?

Minus sign iconPlus sign iconMaxCyte, Inc.'s official website is maxcyte.com and has social profiles on LinkedInCrunchbase.

What is MaxCyte, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconMaxCyte, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MaxCyte, Inc. have currently?

Minus sign iconPlus sign iconAs of May 2026, MaxCyte, Inc. has approximately 106 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. M.Chief Executive Officer: M. D.Chief Executive Officer: S. D.. Explore MaxCyte, Inc.'s employee directory with LeadIQ.

What industry does MaxCyte, Inc. belong to?

Minus sign iconPlus sign iconMaxCyte, Inc. operates in the Biotechnology Research industry.

What technology does MaxCyte, Inc. use?

Minus sign iconPlus sign iconMaxCyte, Inc.'s tech stack includes GitHubAkamaiZendeskGoogle Fonts APIOpenAIDataTablesAcquia Cloud PlatformC.

What is MaxCyte, Inc.'s email format?

Minus sign iconPlus sign iconMaxCyte, Inc.'s email format typically follows the pattern of FirstL@maxcyte.com. Find more MaxCyte, Inc. email formats with LeadIQ.

How much funding has MaxCyte, Inc. raised to date?

Minus sign iconPlus sign icon As of May 2026, MaxCyte, Inc. has raised $1.7M in funding. The last funding round occurred on Dec 16, 2014 for $1.7M.

When was MaxCyte, Inc. founded?

Minus sign iconPlus sign iconMaxCyte, Inc. was founded in 1999.

MaxCyte, Inc.

Biotechnology ResearchMaryland, United States51-200 Employees

We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™, DTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health.

Section iconCompany Overview

Headquarters
9713 Key West Avenue Suite 400 Rockville, Maryland 20850 United States
Phone number
+1-301-944-****
Website
maxcyte.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MXCT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $1.7M

    MaxCyte, Inc. has raised a total of $1.7M of funding over 8 rounds. Their latest funding round was raised on Dec 16, 2014 in the amount of $1.7M.

  • $25M$50M

    MaxCyte, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $1.7M

    MaxCyte, Inc. has raised a total of $1.7M of funding over 8 rounds. Their latest funding round was raised on Dec 16, 2014 in the amount of $1.7M.

  • $25M$50M

    MaxCyte, Inc.'s revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    M. M.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G.
    Chief Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. H.
    Chief Financial Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Senior Vice President & Head, Global Sales
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. H.
    Senior Vice President - Corporate Development And Strategy
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. E.
    Vice President, Information Technology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. K.
    Senior Vice President Of Product Development And Engineering
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.